OBJECTIVE: Safe and effective vaginally applied microbicides could help to control the continuing spread of sexually transmitted diseases. STUDY DESIGN: This study used nonhuman primates to test the effects of multiple applications of nonoxynol 9, benzalkonium chloride, or a combination on vaginal flora and lower reproductive tract tissues. Fourteen monkeys (Macaca nemestrina) received daily vaginal applications of nonoxynol 9, benzalkonium chloride, or both for 3 to 4 days. Vaginal microflora and colposcopic observations were made at baseline and during and after completion of treatments. Cervical biopsy specimens were collected from a subset of animals. RESULTS: Cervical erythema and vaginal erythema were observed in all 3 treatment groups. Cervical papillae and epithelial disruption were present in both the nonoxynol 9 and the nonoxynol 9 plus benzalkonium chloride groups. Vaginal epithelial disruption was noted in both the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Cervical biopsy specimens from each group revealed acute inflammatory infiltrates with occasional plasma cells and lymphoid follicles. Detection of most microorganisms, including viridans streptococci, decreased in the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Detection of Lactobacillus species decreased in the benzalkonium chloride group. All microflora levels recovered after several days without microbicide use. CONCLUSIONS: Although nonoxynol 9 is currently the only microbicide approved for use as a spermicide in the United States, its repeated use may be detrimental to the epithelial tissues of the female reproductive tract. Benzalkonium chloride, currently approved for use in other countries, not only may damage epithelial tissues but also appears to reduce the population of potentially protective Lactobacillus species in the vagina.
OBJECTIVE: Safe and effective vaginally applied microbicides could help to control the continuing spread of sexually transmitted diseases. STUDY DESIGN: This study used nonhuman primates to test the effects of multiple applications of nonoxynol 9, benzalkonium chloride, or a combination on vaginal flora and lower reproductive tract tissues. Fourteen monkeys (Macaca nemestrina) received daily vaginal applications of nonoxynol 9, benzalkonium chloride, or both for 3 to 4 days. Vaginal microflora and colposcopic observations were made at baseline and during and after completion of treatments. Cervical biopsy specimens were collected from a subset of animals. RESULTS: Cervical erythema and vaginal erythema were observed in all 3 treatment groups. Cervical papillae and epithelial disruption were present in both the nonoxynol 9 and the nonoxynol 9 plus benzalkonium chloride groups. Vaginal epithelial disruption was noted in both the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Cervical biopsy specimens from each group revealed acute inflammatory infiltrates with occasional plasma cells and lymphoid follicles. Detection of most microorganisms, including viridans streptococci, decreased in the benzalkonium chloride and the nonoxynol 9 plus benzalkonium chloride groups. Detection of Lactobacillus species decreased in the benzalkonium chloride group. All microflora levels recovered after several days without microbicide use. CONCLUSIONS: Although nonoxynol 9 is currently the only microbicide approved for use as a spermicide in the United States, its repeated use may be detrimental to the epithelial tissues of the female reproductive tract. Benzalkonium chloride, currently approved for use in other countries, not only may damage epithelial tissues but also appears to reduce the population of potentially protective Lactobacillus species in the vagina.
Authors: F C Krebs; S R Miller; B J Catalone; P A Welsh; D Malamud; M K Howett; B Wigdahl Journal: Antimicrob Agents Chemother Date: 2000-07 Impact factor: 5.191
Authors: Kathleen L Vincent; Nigel Bourne; Brent A Bell; Gracie Vargas; Alai Tan; Daniel Cowan; Lawrence R Stanberry; Susan L Rosenthal; Massoud Motamedi Journal: Sex Transm Dis Date: 2009-05 Impact factor: 2.830
Authors: Alexander M Cole; Dorothy L Patton; Lisa C Rohan; Amy L Cole; Yvonne Cosgrove-Sweeney; Nicole A Rogers; Deena Ratner; Alexandra B Sassi; Carol Lackman-Smith; Patrick Tarwater; Bharat Ramratnam; Piotr Ruchala; Robert I Lehrer; Alan J Waring; Phalguni Gupta Journal: PLoS One Date: 2010-11-29 Impact factor: 3.240
Authors: Bradley J Catalone; Tina M Kish-Catalone; Lynn R Budgeon; Elizabeth B Neely; Maelee Ferguson; Fred C Krebs; Mary K Howett; Mohamed Labib; Robert Rando; Brian Wigdahl Journal: Antimicrob Agents Chemother Date: 2004-05 Impact factor: 5.191
Authors: Andrea M Weiler; Qingsheng Li; Lijie Duan; Masahiko Kaizu; Kim L Weisgrau; Thomas C Friedrich; Matthew R Reynolds; Ashley T Haase; Eva G Rakasz Journal: J Virol Date: 2008-02-13 Impact factor: 5.103
Authors: Patrick M Schlievert; Kristi L Strandberg; Amanda J Brosnahan; Marnie L Peterson; Stefan E Pambuccian; Karla R Nephew; Kevin G Brunner; Nancy J Schultz-Darken; Ashley T Haase Journal: Antimicrob Agents Chemother Date: 2008-10-06 Impact factor: 5.191
Authors: Rachel Singer; Paul Mawson; Nina Derby; Aixa Rodriguez; Larisa Kizima; Radhika Menon; Daniel Goldman; Jessica Kenney; Meropi Aravantinou; Samantha Seidor; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Melissa Robbiani; Thomas M Zydowsky Journal: Sci Transl Med Date: 2012-09-05 Impact factor: 17.956